Gunman kills self after shooting doctor in parking lot of Affinity Medical Center in Massillon | WeForNews | Latest News, Blogs Gunman kills self after shooting doctor in parking lot of Affinity Medical Center in Massillon – WeForNews | Latest News, Blogs
Connect with us

World

Gunman kills self after shooting doctor in parking lot of Affinity Medical Center in Massillon

Both Wood and Seese were taken inside the hospital to be treated for their injuries. Both men died as a result of their wounds.

Published

on

Affinity Medical

MASSILLON, Ohio – A doctor was shot in the parking lot of Affinity Medical Center in Massillon Monday afternoon and then the gunman turned the gun on himself, according to Massillon police.

The gunman, Michael Wood, died from the self-inflicted injuries in the parking lot, police said.

The shooting happened just after 2 p.m. Police Capt. Bill Peel said the doctor, Dr. George Seese, was walking to his SUV when he was shot. Capt. Peel said he believes Seese was shot twice.

Both Wood and Seese were taken inside the hospital to be treated for their injuries. Both men died as a result of their wounds.

Police also said it appeared the doctor was targeted. A preliminary investigation reveals the two shared a mutual love interest. Police say Wood confronted Dr. Seese at his car, then Wood shot Seese. Then, Wood walked to his car, which was parked behind the doctor’s, and shot himself.

Authorities recommended that local schools go on lockdown because the shooter may be on the loose. Police said they thought the suspect might have taken off because a vehicle sped away from the scene at the time of the shooting.

According to authorities, that vehicle ended up being unrelated to the shooting.

Massillon City Schools were placed on lockdown for a brief time. The district posted this statement to its Facebook page:

The safety of our students and staff is always our number one priority. This afternoon, the Massillon Police Department notified us that there was a safety concern within the community. The Massillon City School District took immediate action and placed each building in lock down for precautionary measures. Police have now notified us that it is safe to come out of lock down. In no circumstance were any of our students or staff in jeopardy. The incident was not on school property. Again, the safety of our students and staff is our number one priority.

Health

Russia: Putin orders mass COVID-19 vaccinations; health minister claims one lakh already received Sputnik V

Museums, theatres and concert halls would be closed to the public in the city of more than 5 million people for the duration of Russia’s New Year holidays, from December 30 to January 10.

Published

on

Russian President Vladimir Putin

Russian Health Minister Mikhail Murashko on Wednesday said more than 100,000 people had already been vaccinated against COVID-19, as Moscow presented its Sputnik V vaccine to the United Nations over video link.

President Vladimir Putin earlier ordered authorities to begin mass voluntary vaccinations next week. Russia will have produced two million vaccine doses within the next few days, Putin said.

Russia said last month that its Sputnik V jab was 92% effective at protecting people from COVID-19 according to interim results.

“Let’s agree on this – you will not report to me next week, but you will start mass vaccination…let’s get to work already,” Putin told Deputy Prime Minister Tatiana Golikova.

Golikova said large-scale vaccination could begin on a voluntary basis in December.

The rise in infections has slowed since reaching a high on November 27, with 25,345 new cases reported on Wednesday.

Russia has resisted imposing lockdowns during the second wave of the virus, preferring targeted regional curbs.

With 2,347,401 infections, Russia has the fourth-largest number of COVID-19 cases in the world behind the United States, India and Brazil. It has recorded 41,053 deaths related to COVID-19 since the start of the pandemic.

The Kremlin earlier gave assurances that Russians were first in line to be vaccinated, with Moscow also discussing supply deals with other countries.

“The absolute priority are Russians,” Kremlin spokesman Dmitry Peskov said. “Production within Russia, which is already being developed, will meet the needs of Russians.”

Authorities in St Petersburg, which reported 3,684 new infections on Wednesday, ordered bars and restaurants to close from December 30 until January 3, to combat the rise in cases there, the RIA news agency reported.

Museums, theatres and concert halls would be closed to the public in the city of more than 5 million people for the duration of Russia’s New Year holidays, from December 30 to January 10.

Continue Reading

Blog

International Day of Persons with Disabilities: Theme, Date and history of the day

International Day of Persons with Disabilities: It aims to increase public awareness, understanding and acceptance of people with disabilities and celebrate their achievements and contributions.

Published

on

By

International Day of Persons with Disabilities

International Day of Persons with Disabilities is an international observance promoted by the United Nations since 1992. It is celebrated on December 3 all around the world. It aims to increase public awareness, understanding and acceptance of people with disabilities and celebrate their achievements and contributions.

IDPD mobilizes support for critical issues relating to the inclusion of persons with disabilities, promotes awareness-raising about disability issues and draws attention to the benefits of an inclusive and accessible society for all.

UN agencies, civil society organizations, academic institutions and the private sector are motivated to support IDPD by collaborating with organizations for people with disabilities to arrange events and activities.

International Day of People with Disability: Theme

The theme for IDPwD 2020 is “Building Back Better: toward a disability-inclusive, accessible and sustainable post COVID-19 World”.

Every year the UN announces a theme to observe for International Day of People with Disability. The annual theme provides an overarching focus on how society can strive for inclusivity through the removal of physical, technological and attitudinal barriers for people with disabilities.

This has been occurring since 1992 when the General Assembly announced 3 December as the International Day of Disabled Persons.

National Disability Strategy 2010–2020

In Australia, the National Disability Strategy 2010–2020 commits all governments to a nationwide approach aimed at improving the lives of disabled people, their families and carers.

The Strategy’s ten-year national framework for reform concentrates on better inclusion for people with disabilities and seeks to create a society that enables people with disabilities to fulfill their potential as equal citizens.

On the 2012 International Day of People with Disability, the United Kingdom government introduced mandatory work for disabled people who received welfare benefits in order to “Improve disabled peoples chances of getting work by mandatory employment”.

A program is also launched on December 3 across India to serve the differently-able community of the country as an initiative called Accessible India Campaign under the Article 9 of UN Convention on the Rights of Persons with Disabilities (UNCRPD)

Continue Reading

Health

UK Approves Pfizer-BioNTech Covid Vaccine For Use, First In The World

The country has ordered up to 40 million doses of the vaccine that is said to offer 95 per cent protection.

Published

on

COVID-19 Vaccine

Pfizer and BioNTech say they’ve won permission Wednesday for emergency use of their Covid-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science — and a major step toward eventually ending the pandemic.

The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe’s deadliest Covid-19 outbreak.

Other countries aren’t far behind: The U.S. and the European Union also are vetting the Pfizer shot along with a similar vaccine made by competitor Moderna Inc.

Pfizer said it would immediately begin shipping limited supplies to the U.K. — and has been gearing up for even wider distribution if given a similar nod by the U.S. Food and Drug Administration, a decision expected as early as next week.

But doses everywhere are scarce, and initial supplies will be rationed until more is manufactured in the first several months of next year.

Pfizer CEO Albert Bourla called the U.K. decision “a historic moment.”

“We are focusing on moving with the same level of urgency to safely supply a high-quality vaccine around the world,” Bourla said in a statement.

While the U.K. has ordered enough Pfizer vaccine for 20 million people, it’s not clear how many will arrive by year’s end and adding to the distribution challenges is that it must be stored at ultra-cold temperatures.

Two doses three weeks apart are required for protection. First in line, the U.K. government says, are frontline health care workers and nursing home residents, followed by older adults.

British regulators also are considering another shot made by AstraZeneca and Oxford University. But Prime Minister Boris Johnson has warned “we must first navigate a hard winter” of restrictions to try to curb the virus until there’s enough vaccine to go around.

Every country has different rules for determining when an experimental vaccine is safe and effective enough to use. Intense political pressure to be the first to roll out a rigorously scientifically tested shot coloured the race in the U.S. and Britain, even as researchers pledged to cut no corners. In contrast, China and Russia have offered different vaccinations to their citizens ahead of late-stage testing.

The shots made by U.S.-based Pfizer and its German partner BioNTech were tested in tens of thousands of people. And while that study isn’t complete, early results suggest the vaccine is 95% effective at preventing mild to severe Covid-19 disease. The companies told regulators that of the first 170 infections detected in study volunteers, only eight were among people who’d received the actual vaccine and the rest had gotten a dummy shot.

“This is an extraordinarily strong protection,” Dr. Ugur Sahin, BioNTech’s CEO, recently told The Associated Press.

The companies also reported no serious side effects, although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections.

But experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed. Still to be determined is whether the Pfizer-BioNTech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts.

The vaccine also has been tested in only a small number of children, none younger than 12, and there’s no information on its effects in pregnant women.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.